Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2022-03-18 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2021 by 华邦生命健康股份有限公司. It references regulatory frameworks related to internal control, such as the "企业内部控制基本规范" and related guidelines issued by the Ministry of Finance and the China Securities Regulatory Commission. The content is a detailed self-assessment of the company's internal control effectiveness, covering control environment, risk assessment, control activities, communication, and defect identification standards. It includes management's opinion on the effectiveness of internal controls as of December 31, 2021. This type of document is a standalone audit-related report focusing on internal control evaluation rather than a full annual report or financial statement. It does not present comprehensive financial results or earnings but focuses on internal control assessment and compliance. Therefore, it fits the category of Audit Report / Information (AR). The document length (8352 characters) and detailed content confirm it is the report itself, not just an announcement or certification. FY 2021
2022-03-18 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 8th Board of Directors 6th meeting of Huabang Life Health Co., Ltd. It includes approvals of various reports such as the 2021 General Manager Work Report, 2021 Board Work Report, 2021 Financial Final Report, 2022 Financial Budget Report, 2021 Profit Distribution Plan, 2021 Annual Report and its summary, 2021 Internal Control Self-Evaluation Report, and others. The document also mentions that these reports will be submitted to the 2021 Annual General Meeting for approval. The document is not the reports themselves but a formal announcement of board meeting decisions and approvals related to management and board activities. It does not contain the full financial data or the reports themselves but references them and states they are published elsewhere. This fits the category of Board/Management Information (MANG) as it announces board meeting resolutions and management reports approval. The document length is 2494 characters, relatively short and mainly an announcement of board decisions rather than the full reports. Therefore, the best classification is MANG with high confidence.
2022-03-18 Chinese
2021年度独立董事述职报告-梁爽
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2021 from Huabang Life Health Co., Ltd. It details the independent director's attendance at board meetings, opinions on various company matters, committee work, investigations, and efforts to protect investor rights. The content is a narrative report on the director's duties and activities during the year, not a financial report or an announcement. It is a specific report related to board/management information, particularly focusing on the independent director's role and performance. The document length is under 5,000 characters but contains substantive content, not just an announcement or certification. Therefore, it fits best under Board/Management Information (MANG).
2022-03-18 Chinese
独立董事年度述职报告
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2021" for Huabang Life Health Co., Ltd. It details the independent director's activities, attendance at board meetings, opinions on various company matters, committee work, investigations, and efforts to protect investor rights during the 2021 fiscal year. The content is a narrative report on the independent director's duties and oversight rather than a financial report or announcement. It is not an annual report, audit report, earnings release, or any other financial statement. It is also not a short announcement or certification but a substantive report on governance and director activities. This fits best under the category of Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities. The document length is 4052 characters, which is substantive enough to be a report rather than a brief announcement. Therefore, the classification is MANG with high confidence.
2022-03-18 Chinese
2021年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2021 年度董事会工作报告' which translates to '2021 Annual Board of Directors Work Report'. It details the activities, meetings, and work of the board of directors throughout the year 2021, including the number of meetings held, the committees' work, and strategic initiatives. It also includes detailed descriptions of governance, internal controls, and company operations related to the board's responsibilities. The document is comprehensive and focuses on the board's work rather than just announcing changes or voting results. It is not a financial report like an annual report (10-K) or interim report (IR), nor is it a simple announcement or certification. It fits best under the category of Board/Management Information (MANG) as it reports on the board's activities and governance work for the year.
2022-03-18 Chinese
华邦健康2021年募集资金存放与使用情况的鉴证报告
Regulatory Filings
2022-03-18 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.